SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Bill Wexler's Profits of DOOM

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bill Wexler who wrote ()8/13/1998 5:54:00 AM
From: Bill Wexler  Read Replies (2) of 4634
 
Reiterate very strong short-sell recs. ALTIF and HEPH

Both stocks were first recommended on this thread when they were well in the teens.

ALTIF currently trades at 7 and HEPH at 11.

Altair (ALTIF) is another mining fraud with an extra added kicker of a bogus "centrifugal jig" technology for mineral separation. There is absolutely nothing to this company except a shell designed to sell worthless stock to victims. Never cover - short to zero. [Note - SI poster "Jas Singh MD" has touted ALTIF. Jas is well known on SI for touting other spectacular frauds such as ZITL and CYBG. I consider him the short-seller's finest contrarian indicator on SI :^D]

Hollis-Eden Pharmaceutical (HEPH) is a biotech fraud which makes Zonagen look like Merck by comparison. HEPH is supposedly working on an AIDS cure based upon DHEA - a compound touted by quacks and nuts as a cure-all and fountain of youth. HEPH executives have extremely sleazy backgrounds. Short to zero.

I'm reiterating these recs now in case the market continues turning up. The rising tide will provide upticks and borrowable stock from the margin accounts of suckers who feel lucky again. Both stocks are squeezable, but HEPH is more dangerous and volatile than ALTIF. Use caution.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext